Clinical Trial Update: Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating proteomic prediction and renin-angiotension-aldosterone system inhibition to prevent early diabetic nephropathy in type 2 diabetics w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Diabetic Retinopathy

Snippet

Sponsor: Peter Rossing | Conditions: Diabetic Nephropathy, Diabetic Retinopathy | Phase 2, Phase 3 | Status: COMPLETED